BETA


2021/2601(DEA) Inclusion of the new psychoactive substances methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) and methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of ‘drug’

Progress: Procedure completed - delegated act enters into force

RoleCommitteeRapporteurShadows
Lead LIBE
Lead committee dossier:

Events

2021/05/22
   EP - Delegated act not objected by Parliament
2021/03/24
   EP - Committee referral announced in Parliament
2021/03/12
   EC - Non-legislative basic document
Documents
2021/03/12
   EC - Non-legislative basic document published
Documents
2021/03/12
   EP/CSL - Initial period for examining delegated act 2 month(s)

Documents

History

(these mark the time of scraping, not the official date of the change)

procedure/subject/4.20.03
Drug addiction, alcoholism, smoking
procedure/subject/7.30.30.04
Action to combat drugs and drug-trafficking
procedure/subject/4.20.03
Drug addiction, alcoholism, smoking
procedure/subject/7.30.30.04
Action to combat drugs and drug-trafficking
events/3
date
2021-05-22T00:00:00
type
Delegated act not objected by Parliament
body
EP
procedure/stage_reached
Old
Awaiting committee decision
New
Procedure completed - delegated act enters into force
events/2/body
EP
events/2
date
2021-03-24T00:00:00
type
Committee referral announced in Parliament
events/2
date
2021-03-24T00:00:00
type
Committee referral announced in Parliament, 1st reading/single reading
body
EP
events/2
date
2021-03-24T00:00:00
type
Committee referral announced in Parliament, 1st reading/single reading
body
EP
procedure/dossier_of_the_committee
  • LIBE/9/05608
procedure/stage_reached
Old
Preparatory phase in Parliament
New
Awaiting committee decision